Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab in Relapsed or Refractory Multiple Myeloma
NCT00482495Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- Apr 2006
- Primary completion
- Dec 2006
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in multiple myeloma (MM), sponsored by Mayo Clinic. Started Apr 2006; status: completed.
02
Drugs
bevacizumab
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00482495.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00482495.